SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00005



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00005_Fib 4 Human HLA-A03_01,HLA-A23_01,HLA-B08_01,HLA-B15_18,HLA-C07_02,HLA-C07_04
SYSMHC00005_HCC1143 3 Human HLA-A31_01,HLA-B35_08,HLA-B37_01,HLA-C04_01,HLA-C06_02
SYSMHC00005_HCC1937 4 Human HLA-A23_01,HLA-A24_02,HLA-B07_02,HLA-B40_01,HLA-C03_04,HLA-C07_02
SYSMHC00005_HCT116 4 Human HLA-A01_01,HLA-A02_01,HLA-B45_01,HLA-B18_01,HLA-C05_01,HLA-C07_01
SYSMHC00005_JY 3 Human HLA-A02_01,HLA-B07_02,HLA-C07_02
SYSMHC00005_SupB15-RT 4 Human HLA-A03_01,HLA-A11_01,HLA-B51_01,HLA-B52_01,HLA-C12_04,HLA-C14_02
SYSMHC00005_SupB15-WT 4 Human HLA-A03_01,HLA-A11_01,HLA-B51_01,HLA-B52_01,HLA-C12_04,HLA-C14_02



Detailed view of sample SYSMHC00005_HCT116



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00005 SYSMHC00005_HCT116 SYSMHC00005_20120619_EXQ6_MiBa_SA_HCT116_2_mHLA_2hr.raw Human In vitro Colon Hct116 adherent Colon carcinoma class I HLA-A01_01,HLA-A02_01,HLA-B45_01,HLA-B18_01,HLA-C05_01,HLA-C07_01 25576301 native Immunoaffinity W6/32 Q-Exactive nanoflow HPLC (Proxeon Biosystems, Thermo Fisher Scientific, Bremen, Germany) no DDA HCD 2-30% ACN 90 75μm id 2 cm 1
SYSMHC00005 SYSMHC00005_HCT116 SYSMHC00005_20120617_EXQ0_MiBa_SA_HCT116_1_mHLA_2hr.raw Human In vitro Colon Hct116 adherent Colon carcinoma class I HLA-A01_01,HLA-A02_01,HLA-B45_01,HLA-B18_01,HLA-C05_01,HLA-C07_01 25576301 native Immunoaffinity W6/32 Q-Exactive nanoflow HPLC (Proxeon Biosystems, Thermo Fisher Scientific, Bremen, Germany) no DDA HCD 2-30% ACN 90 75μm id 2 cm 2
SYSMHC00005 SYSMHC00005_HCT116 SYSMHC00005_20120515_EXQ3_MiBa_SA_HCT116_mHLA-1.raw Human In vitro Colon Hct116 adherent Colon carcinoma class I HLA-A01_01,HLA-A02_01,HLA-B45_01,HLA-B18_01,HLA-C05_01,HLA-C07_01 25576301 native Immunoaffinity W6/32 Q-Exactive nanoflow HPLC (Proxeon Biosystems, Thermo Fisher Scientific, Bremen, Germany) no DDA HCD 2-30% ACN 90 75μm id 2 cm 3
SYSMHC00005 SYSMHC00005_HCT116 SYSMHC00005_20120518_EXQ0_MiBa_SA_HCT116_mHLA-2.raw Human In vitro Colon Hct116 adherent Colon carcinoma class I HLA-A01_01,HLA-A02_01,HLA-B45_01,HLA-B18_01,HLA-C05_01,HLA-C07_01 25576301 native Immunoaffinity W6/32 Q-Exactive nanoflow HPLC (Proxeon Biosystems, Thermo Fisher Scientific, Bremen, Germany) no DDA HCD 2-30% ACN 90 75μm id 2 cm 4